Đang tải... (xem toàn văn)
We will objectively assess the financial situation of selectedpharmaceutical companies: DHG - Hau Giang Pharmaceutical Joint Stock Company, DCL - CuuLong Pharmaceutical Joint Stock Compa
Trang 1GROUP ASSIGNMENT
Analysis Of Financial Statements Of Companies Inthe Pharmaceutical Industry Within Three Years Of
2020, 2021 And 2022 Subject: ACC101
Class: MC1805
Lecturer: Tô Thị Thùy DươngGroup Member:
Huỳnh Mạnh Cường - SS170340Trần Nguyễn Hoàng Anh - SE173276Lê Anh Quân - SE173047
Nguyễn Thị Lan Anh - SS170762Lê Thị Thu Hương - SS170196Võ Xuân Anh Quân - SE140236
Trang 2Table of Content
1 DHG - Hau Giang Pharmaceutical Joint Stock Company 32 DCL - Cuu Long Pharmaceutical Joint Stock Company 3
4 IMP - IMEXPHARM Pharmaceutical Joint Stock Company 4
Trang 3We wrote this report for the purpose of comparing the financial statements of pharmaceuticalcompanies by applying the learned ratios We will objectively assess the financial situation of selectedpharmaceutical companies: DHG - Hau Giang Pharmaceutical Joint Stock Company, DCL - CuuLong Pharmaceutical Joint Stock Company, OPC - Pharmaceutical Joint Stock Company OPCproducts, IMP - IMEXPHARM Pharmaceutical Joint Stock Company.
1 DHG - Hau Giang Pharmaceutical Joint StockCompany
- The predecessor of Hau Giang Pharmaceutical Joint StockCompany is 2/9 Pharmaceutical Factory, established onSeptember 2, 1974 at Kenh 5 Dat Set, Khanh Lamcommune (now Khanh Hoa commune), U Minh district,Ca Mau province Quickly.
- September 2, 2004: Hau Giang Pharmaceutical Complex
Enterprise, City Can Tho transformed its operating model into Hau Giang PharmaceuticalJoint Stock Company and officially went into operation with an initial charter capital of VND80 billion.
- The company started listing with stock code DHG on December 21, 2006 on Ho Chi MinhCity Stock Exchange, offering a price of 320,000 VND/share.
Business activities:- Medicine- Food supplement- Cosmeceuticals- Print package
2 DCL - Cuu Long Pharmaceutical Joint Stock Company- Cuu Long Pharmaceutical Joint Stock Company, formerly
known as Cuu Long Pharmaceutical Enterprise, was establishedin 1976
- In 1992, after Cuu Long province split into Vinh Long and TraVinh provinces, the company changed its name to Cuu LongPharmaceutical and Medical Supplies Company.- In August 2004, the Company was equitized and officially
transformed into a joint stock company from January 1, 2005with the name of CAU LONG PHARMACEUTICAL JOINTSTOCK COMPANY (PHARIMEXCO).
- On September 17, 2008, DCL shares were officially listed and traded on the Ho Chi MinhCity Stock Exchange HCM.
Business activities:
- Manufacturing, trading and direct import and export: pharmaceuticals, capsules, tools,medical equipment for the pharmaceutical industry, medical industry, cosmetics, nutritionalfoods, medicinal materials, chemicals, raw materials raw materials and other pharmaceuticalpreparations.
- Producing all kinds of packaging used in the pharmaceutical industry.- Cultivation of medicinal herbs
Trang 4- Trading and performing information technology services.3 OPC - OPC Pharmaceutical Joint Stock Company
- OPC Pharmaceutical Joint Stock Company, formerly known as TW26 Pharmaceutical Enterprise - OPC, was established in October1977 under Decision No 1176/BYT-QD dated October 24, 1977 ofthe Ministry of Health from the merger 8 private apothecaries inSaigon formerly.
- On February 8, 2002, the Prime Minister issued Decision No.138/QD-TTg on the transformation of Central PharmaceuticalEnterprise 26 under the Vietnam Pharmaceutical Corporation -Ministry of Health into OPC Pharmaceutical Joint Stock Company.
The initial charter capital of the Company upon equitization is 20 billion VND, of which thestate holding rate is 29%.
- On October 20, 2008, the Ho Chi Minh Stock Exchange issued an official letter approving theregistration of listing shares for OPC Pharmaceutical JSC, business registration certificate No.4103000893 issued by the City Department of Planning and Investment First issued by HoChi Minh City on March 25, 2002, with the sixth change on January 18, 2008, charter capital:VND 81,900,000,000, official transaction date October 30, 2008
Business activities:
- Trading, planting and processing medicinal herbs;
- Manufacturing and trading in pharmaceuticals, supplies, medical machinery and equipment,chemicals, cosmetics, food, food
- functional products, wine and alcoholic beverages, carbonated drinks;- Prepare prescription drugs;
- Consulting, scientific and technical services, technology transfer in the field of medicine andpharmacy;
- Import and export business in the field of medicine and pharmacy;4 IMP - IMEXPHARM Pharmaceutical Joint Stock Company- The predecessor of Imexpharm pharmaceutical company is Dong
Thap Pharmaceutical Union Enterprise, under the Dong ThapDepartment of Health In November 1992, Dong ThapPharmaceutical Union was renamed as Dong Thap
Pharmaceutical Company, under Dong Thap People's Committee- November 1999 Dong Thap Pharmaceutical Company changed its
name to Central Pharmaceutical Company 7 under the VietnamPharmaceutical Corporation
- In July 2001, Central Pharmaceutical Company 7 changed into
Imexpharm pharmaceutical company with charter capital of 22 billion VND.
- The company started listing with the code IMP on December 4, 2006 on the Ho Chi MinhCity Stock Exchange.
Trang 5III.Data analysis:
1 Liquidity ratios:A Current ratio:
a Definition:
The current ratio measures a company’s ability to pay short-term obligations or those due within oneyear It tells investors and analysts how a company can maximize the current assets on its balancesheet to satisfy its current debt and other payables.
The current ratio is equal to 1: may indicate that the company is operating at a minimum level tomaintain its ability to pay its debts This can pose some risk, especially during a financial crisis orwhen there are sudden fluctuations in cash flows If the company is in financial trouble, paying offdebt can become difficult and lead to serious financial problems.
The current ratio is greater than 1: The company has the ability to pay short-term liabilities with itscurrent assets A current ratio greater than 1 indicates a company is more financially viable and lessdependent on borrowing or selling assets to pay off debt.
c Data from selected companies:DHG - Hau Giang Pharmaceutical Joint Stock Company
Current assets 3.475.797.124.506 3.720.882.994.624 4.218.772.327.716Current Liabilities 878.652.181.871 757.700.006.863 811.536.702.268
DCL - Cuu Long Pharmaceutical Joint Stock Company
Current assets 1.028.307.485.392 838.210.231.273 962.346.195.866Current Liabilities 280.007.773.941 600.623.688.861 476.721.469.516
OPC - OPC Pharmaceutical Joint Stock Company
Current assets 484.836.537.434 601.100.535.457 635.592.351.771Current liabilities 202.262.867.143 271.021.414.762 161.137.789.769
Trang 62020 2021 2022Current assets 981.975.300.723 1.176.339.787.490 1.103.552.901.572Current liabilities 346.969.098.434 408.638.192.302 382.496.674.756
d Evaluate:
In general, DHG, DCL, OPC and IMP companies all have stable and quite high current ratios,showing relatively good short-term debt solvency However, there are still differences betweencompanies:
- The current ratio of DHG in all three years is high, from 4.0 to 5.2 This shows that thecompany is able to pay off its short-term debt with its short-term assets easily DHG hassufficient short-term assets to meet its short-term liabilities without using additional fundingsources.
- The current ratio of DCL has fluctuated significantly from 2020 to 2022 In 2021, the currentratio decreased significantly to 1.4, while in 2022, it increased to 2.0 A current ratio lowerthan 1 in 2021 may indicate that the company is having difficulty paying off its short-termdebt with its current assets, and may need to find additional funding.
- Current ratio of OPC and IMP in all three years are stable from 2.2 to 3.9 and 2.8 to 2.9 Thisratio shows that the company is able to pay off its short-term liabilities with its current assetswith relative ease OPC and IMP have good financial flexibility and ability to maintainliquidity.
B Acid-test ratio:a Definition:
The Acid-Test Ratio, also known as the quick ratio, is a liquidity ratio that measures how sufficient acompany’s short-term assets are to cover its current liabilities In other words, the acid-test ratio is ameasure of how well a company can satisfy its short-term (current) financial obligations.
b Formula:
𝐴𝑐𝑖𝑑 − 𝑡𝑒𝑠𝑡 𝑟𝑎𝑡𝑖𝑜 = 𝐶𝑢𝑟𝑟𝑒𝑛𝑡 𝑙𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠𝑄𝑢𝑖𝑐𝑘 𝐴𝑠𝑠𝑒𝑡𝑠 = 𝐶𝑎𝑠ℎ + 𝑆−𝑇 𝐼𝑛𝑣𝑒𝑠𝑡𝑚𝑒𝑛𝑡𝑠 + 𝑅𝑒𝑐𝑒𝑖𝑣𝑎𝑏𝑙𝑒𝑠𝐶𝑢𝑟𝑟𝑒𝑛𝑡 𝑙𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑖𝑒𝑠Acid-test ratio less than 1: This indicates that the company has the ability to pay short-termliabilities with assets that are easily convertible into cash The company may have to rely on sellinglong-term assets or using other sources of funding to secure debt payments An Acid-test ratio of lessthan 1 may indicate an unstable debt payment situation and may pose a financial risk.
The acid-test ratio is equal to 1: This means that the value of a company's current assets that arereadily convertible into cash is sufficient to cover its short-term liabilities Although the company hasthe ability to pay off debt, there is no excess to ensure flexibility in debt repayment An Acid-test ratio
Trang 7of 1 can indicate that the company is maintaining a minimum level to ensure debt solvency, but mayface difficulties in an unexpected situation or financial crisis.
Acid-test ratio greater than 1: This means that the company has the ability to pay its short-termliabilities with assets that are easily convertible into cash An Acid-test ratio greater than 1 indicatesthat the company is able to pay off debt easily and flexibly, without the need to use additional fundingsources or sell assets This shows a stable financial situation and the ability to cope with unexpectedfluctuations.
c Data from selected companies:DHG - Hau Giang Pharmaceutical Joint Stock Company
Short term
investment 2.074.000.000.000 2.110.000.000.000 2.355.000.000.000Current
receivable 496.020.199.824 488.071.438.874 550.503.358.957Current
receivable 252.304.346.512 179.934.712.264 495.512.807.843Current
investment 68.954.572 68.954.572 209.968.954.572Current
receivable 137.123.155.715 127.243.186.490 171.928.713.130Current liabilities 202.262.867.143 271.021.414.762 161.137.789.769
Trang 82020 2021 2022Cash 85.268.705.365 271.272.865.376 178.845.070.328Short term
investment 63.607.855.260 112.452.800.000 211.300.000.000Current
receivable 398.091.289.641 295.062.515.167 270.938.803.795Current liabilities 346.932.038.104 408.638.192.302 352.496.674.756
- OPC: OPC's acid-test ratio has increased significantly from 2020 to 2022 This indexincreased from 0.9 to 2.8, showing the company's ability to pay short-term liabilities withassets easily converted into cash with relative ease and flexibility.
C Day’s Sales in Inventory:a Definition:
Days' Sales in Inventory (DSI) is a financial metric used to measure the average number of days ittakes for a company to sell its inventory It is also referred to as the number of days' inventory onhand.
b Formula:
𝐷𝑎𝑦𝑠’ 𝑆𝑎𝑙𝑒𝑠 𝑖𝑛 𝐼𝑛𝑣𝑒𝑛𝑡𝑜𝑟𝑦 = 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝐼𝑛𝑣𝑒𝑛𝑡𝑜𝑟𝑦 𝐶𝑜𝑠𝑡 𝑜𝑓 𝑔𝑜𝑜𝑑𝑠 𝑠𝑜𝑙𝑑 * 365c Data from selected companies:
DHG - Hau Giang Pharmaceutical Joint Stock Company
Average Inventory 826.585.429.976 950.806.732.036.5 1,161,719,714,080COGS 1.944.243.042.082 2.082.259.824.914 2.418.521.064.699Day’s Sales in
Inventory
Trang 92020 2021 2022Average Inventory 215,169,227,178 254,900,360,421 299,302,695,816
Day’s Sales inInventory
d Evaluate:
In general, companies have differences in DSI values, however, DSI values are at a relatively lowlevel and show that companies have an efficient ability to turn around and consume inventory.Specifically:
- DHG's DSI increased from 2020 to 2022, suggesting that the company maintains inventoryfor a longer period of time before selling it off However, the DSI value is still relatively low,showing that the company has the ability to consume inventory efficiently.
- DCL's DSI increased from 2020 to 2021, but decreased significantly in 2022 DCL's DSIvalue in 2022 is the lowest in years, showing that the company consumes inventory quickly.- OPC's DSI declined continuously from 2020 to 2022, indicating that the company consumedinventory faster over time OPC's DSI value in 2022 is the lowest in years, showing that thecompany manages its inventory effectively.
- IMP's DSI increased from 2020 to 2021, but decreased in 2022 IMP's DSI value in 2021 isthe highest in years, suggesting the company maintains inventory for a longer period of timebefore selling it out
Trang 10D Days Sales Uncollected:a Definition:
Is a financial metric used to measure the average time it takes a company to collect money from acustomer after a sale This metric shows the average number of days a company has to wait to collectmoney from a customer.
b Formula:
𝐷𝑎𝑦𝑠 𝑆𝑎𝑙𝑒𝑠 𝑈𝑛𝑐𝑜𝑙𝑙𝑒𝑐𝑡𝑒𝑑 = 𝑁𝑒𝑡 𝑎𝑛𝑛𝑢𝑎𝑙 𝑐𝑟𝑒𝑑𝑖𝑡 𝑠𝑎𝑙𝑒𝑠𝐴𝑐𝑐𝑜𝑢𝑛𝑡 𝑅𝑒𝑐𝑒𝑖𝑣𝑎𝑏𝑙𝑒 * 365c Data from selected companies:
DHG - Hau Giang Pharmaceutical Joint Stock Company
Accounts Receivable 496.020.199.824 488.071.438.874 550.503.358.957Net annual credit sales 3.755.619.311.324 4.003.163.917.775 4.676.016.007.827Days Sales
DCL - Cuu Long Pharmaceutical Joint Stock Company
Accounts Receivable 288.736.575.421 233.633.989.883 776.382.287.481
Net annual credit sales 671.246.206.966 703.634.340.577 1.015.685.512.758
Days Sales Uncollected 157,005 121,194 279,003OPC - OPC Pharmaceutical Joint Stock Company
Accounts Receivable 149.278.338.347 133.380.003.104 172.336.453.588
Net annual credit sales 965.590.544.373 1.123.727.917.160 1.171.614.107.848
Days Sales Uncollected 56,428 43,323 53,689
IMP - IMEXPHARM Pharmaceutical Joint Stock Company
Accounts Receivable 398.091.289.641 295.062.515.167 270.938.803.795Net annual credit sales 1.369.421.714.781 1.266.596.707.350 1.643.706.514.646Days Sales
d Evaluate:
Overall, companies have differences in DSU values, however, DSU values are relatively low andshow that companies are able to effectively collect money from customers:
Trang 11- DHG's DSU decreased from 2020 to 2022, indicating the company reduced wait times tocollect money from customers after a sale DSU values in the years are relatively low,showing that the company has the ability to collect money from customers quickly.- DCL's DSU decreased significantly from 2020 to 2021, but increased sharply in 2022 DSU
value in 2022 is the highest in years, indicating that the company has to wait longer to collectmoney from customers after the sale.
- OPC's DSU decreased from 2020 to 2021, but increased again in 2022 The DSU value in2021 is the lowest in years, showing the company's ability to collect money from customersquickly.
- IMP's DSU decreases from 2020 to 2021, and continues to decrease in 2022 DSU values inall years are at a relatively low level, showing that the company has the ability to collectmoney from customers quickly.
2 Profitability ratios:A Gross profit margin:
a Definition:
A financial ratio that measures a company's gross profit, i.e profit after deducting costs of goods soldand costs directly related to the company's products or services This ratio indicates how much profit acompany can generate from producing or providing products and services.
b Formula:
𝑁𝑒𝑡 𝑠𝑎𝑙𝑒𝑠c Data from selected companies:
DHG - Hau Giang Pharmaceutical Joint Stock Company
gross margin 1,811,376,269,242 1,920,904,092,861 2,257,494,943,128Net Sales 3,755,619,311,324 4,003,163,917,775 4,676,016,007,827Cost of good sold 1,944,243,042,082 2,082,259,824,914 2,418,521,064,699gross margin ratio 48.23% 47.98% 48.27%
DCL - Cuu Long Pharmaceutical Joint Stock Company
2020 2021 2022gross margin 139,193,370,779 158,735,292,160 212,233,759,252Net Sale 624,093,643,324 654,936,735,647 946,314,827,478Cost of good sold 484,900,272,545 496,201,443,487 734,081,068,226gross margin ratio 22.30% 24.23% 22.42%
Trang 122020 2021 2022gross margin 341,317,872,141 402,199,578,080 450,423,900,833Net Sale 747,588,883,338 931,035,982,003 1,088,510,637,416Cost of good sold 406,271,011,197 528,836,403,923 638,086,736,583gross margin ratio 45.65% 43.199 41.380
IMP - IMEXPHARM Pharmaceutical Joint Stock Company
gross margin 547,045,578,338 488,001,326,263 697,355,250,216Net Sale 1,369,421,714,781 1,266,596,707,350 1,643,706,514,646Cost of good sold 822,376,136,443 778,595,381,087 946,351,264,430gross margin ratio 39.94% 38.52% 42.42%
- IMP's Gross profit margin index fluctuates from 38.52% in 2021 to 42.42% in 2022, but is ina fairly stable range IMP shows the ability to improve gross profit and cost of goods sold in2022.
B Return on assets:a Definition:
Return on Assets (ROA) is a financial metric used to evaluate the profitability of a company's assets.It measures the company's ability to generate profit from its assets.
ROA is expressed as a percentage and indicates the proportion of profit generated by the companyrelative to its total assets A higher ROA indicates that the company is using its assets efficiently togenerate profit Conversely, a lower ROA may suggest that the company is struggling to effectivelyutilize its assets to generate returns.
ROA is an important financial ratio in financial analysis, helping investors and managers assess thefinancial performance of a company and compare it to other companies in the same industry or overtime.
b Formula:
𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑇𝑜𝑡𝑎𝑙 𝐴𝑠𝑠𝑒𝑡𝑠c Data from selected companies: